Work

A phase I study of talotrexin (PT-523) in patients with relapsed or refractory non-small cell lung cancer (NSCLC)

Year: 2006

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.24.18_suppl.7142

Authors: C. S. Rocha Lima, S. V. Orlov, J. Garst, G. M. Manikhas, A. Dowlati, J. A. Quesada, C. Andrews, M. L. Ramirez, G. S. Choy, G. Berk

Institutions: University of Miami, University Hospitals of Cleveland, Duke Medical Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2223502136

Cites:

Cited by: 3

Related to: 10